Disease Burden on PET Predicts Outcomes for Advanced NSCLC Patients Treated with First-Line Immunotherapy. Andraos TY, Halmos B, Cheng H, Huntzinger C, et al. Clin Lung Cancer 2022;23:291-299.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Andraos TY, Halmos B, Cheng H, Huntzinger C, et al. Disease Burden on PET Predicts Outcomes for Advanced NSCLC Patients Treated with First-Line Immunotherapy. Clin Lung Cancer 2022;23:291-299.
PMID: 35382980